88IV - Public company info - Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.

Input the stock code or the company name

Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. - H Shares, 06990.HK - Cash Flow	2022-12	2021-12
Net Cash Flow from Operating Activities	-270,847	-485,942
Net Cash Flow from Return on Investments & Servicing of Finance	-2,927	-39,989
Interest Received	0	0
Interest Paid	-2,927	-39,989
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-32,150	-94,384
Additions to Fixed Assets	-33,659	-94,083
Disposal of Fixed Assets	6,329	0
Increase in Investments	-370,000	-140,000
Decrease in Investments	370,513	140,359
Net Cash Flow with Related Parties	248,000	185,484
Others	-253,333	-186,144
Net Cash Flow before Financing Activities	-305,924	-620,315
Net Cash Flow from Financing Activities	316,379	687,305
New Loans	115,000	30,000
Loans Repayment	-46,621	-61,990
Fixed Income/Debt Instruments	0	511,783
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	0	22,028
Net Cash Flow with Related Parties	248,000	185,484
Others	0	0
Increase(Decrease) in Cash & Cash Equivalents	10,455	66,990
Cash & Cash Equivalents at Beginning of Year	81,793	16,189
Net Cash Flow due to Change in Exchange Rate/Others	712	-1,386
Cash & Cash Equivalents at End of Year	92,960	81,793
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. - H Shares , 06990.HK